Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin in Adults With Scabies
NCT05875441Phase 2Completed
- Sponsor
- Medicines Development for Global Health
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Allosteric Modulators
- Countries
- 4
01
Overview
A Phase 2 trial of moxidectin in scabies, sponsored by Medicines Development for Global Health. Started Nov 2023; status: completed.
02
Drugs
moxidectin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT05875441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05875441.